Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript July 31, 2024Teva Pharmaceutical Industries Limited beats earnings expectations.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Slate Path Capital David Greenspan | 20,191,184 | $328,106,740 | -25% | 6.24% |
| 2. | Rubric Capital Management David Rosen | 17,261,741 | $280,503,291 | -3% | 7.35% |
| 3. | Millennium Management Israel Englander | 12,128,177 | $197,082,876 | +13% | 0.09% |
| 4. | Glenview Capital Larry Robbins | 9,157,641 | $148,811,666 | +23% | 2.92% |
| 5. | Point State Capital Zach Schreiber | 9,146,723 | $148,634,249 | +80% | 3.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.60 | 104,500 | Director | 220,442 | 2019-06-04 | Filing | |
| $8.98 | 111,000 | Director | 115,942 | 2019-06-03 | Filing | |
| $21.92 | 2,000 | Officer | 6,445 | 2018-08-03 | Filing | |
| $19.32 | 250,000 | Director | 1,500,000 | 2018-05-10 | Filing | |
| $19.21 | 500,000 | Director | 1,250,000 | 2018-05-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.30 | 98,943 | 0 | 2024-08-12 | Filing | ||
| $17.28 | 4,065 | 8,848 | 2024-08-09 | Filing | ||
| $17.38 | 45,060 | 0 | 2024-08-09 | Filing | ||
| $17.25 | 24,537 | 45,060 | 2024-08-01 | Filing | ||
| $17.03 | 519,000 | 981,000 | 2024-06-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 41,664,861 | $434,981,150 | 0.01% | |
| 2. | 40,327,407 | $421,018,130 | 27.96% | |
| 3. | 34,383,192 | $404,315,484 | 6.68% | |
| 4. | 34,457,656 | $359,737,929 | 17.31% | |
| 5. | 28,128,744 | $293,664,087 | 2.47% |
News See All
10 Best Robinhood Stocks Under $20
The market reacted favorably after the Federal Reserve’s June 11-12 meeting. The broader market marked record closes.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $-0.12161 EPS, expectations were $0.51.
5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
5 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $1, expectations were $0.75.
Here’s Why Teva Pharmaceutical Industries Limited (TEVA) Rose in Q3
Sound Shore Management, an investment management firm, has released its investor letter for the third quarter of 2023. A copy of the same can be downloaded here.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Q3 2023 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today.
13 Most Undervalued Pharma Stocks To Buy According To Analysts
In this piece, we will take a look at the 13 most undervalued pharmaceutical stocks to buy according to analysts.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
Billionaire Hedge Funds
